Resumen de acción 241
Alibaba Health Information Technology Limited, un holding de inversión, se dedica a la venta directa de productos farmacéuticos, a la plataforma de comercio electrónico de productos farmacéuticos y a los negocios de servicios sanitarios y digitales en China continental y Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Alibaba Health Information Technology Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.27 |
| 52 Week High | HK$5.82 |
| 52 Week Low | HK$2.59 |
| Beta | 1.03 |
| 1 Month Change | 23.86% |
| 3 Month Change | -3.82% |
| 1 Year Change | -30.13% |
| 3 Year Change | -85.07% |
| 5 Year Change | -56.69% |
| Change since IPO | 155.47% |
Noticias y actualizaciones recientes
Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21
Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12Recent updates
Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Rentabilidad de los accionistas
| 241 | HK Consumer Retailing | Mercado HK | |
|---|---|---|---|
| 7D | 3.2% | 2.4% | 4.8% |
| 1Y | -30.1% | -41.8% | 0.6% |
Rentabilidad vs. Industria: 241 superó al sector Hong Kong Consumer Retailing , que obtuvo un rendimiento del -53.4% el año pasado.
Rentabilidad vs. Mercado: 241 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -9.1% el año pasado.
Volatilidad de los precios
| 241 volatility | |
|---|---|
| 241 Average Weekly Movement | 7.4% |
| Consumer Retailing Industry Average Movement | 8.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.4% |
| 10% least volatile stocks in HK Market | 3.7% |
Precio estable de las acciones: 241 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 241 (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1998 | 1,547 | Difan Shen | www.alihealth.cn |
Alibaba Health Information Technology Limited, una sociedad de cartera de inversiones, se dedica a la venta directa de productos farmacéuticos, plataformas de comercio electrónico de productos farmacéuticos y servicios sanitarios y digitales en China continental y Hong Kong. Ofrece una gama de medicamentos con receta, medicamentos de venta libre, suplementos nutricionales, dispositivos médicos, lentes de contacto y otros productos relacionados con la salud a través de sus tiendas en línea en Tmall.com y puntos de venta de farmacia fuera de línea a clientes de empresa a cliente y de empresa a empresa; y productos farmacéuticos, dispositivos médicos y productos sanitarios, alimentos saludables, productos para adultos y de planificación familiar, lentes de contacto y servicios médicos y sanitarios a través de su plataforma de comercio electrónico. La empresa también ofrece servicios médicos y sanitarios, como revisiones médicas, pruebas de ácido nucleico, consultas médicas, registros, vacunación y medicina tradicional china a través de varios canales, como Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk y Quark.
Resumen de fundamentos de Alibaba Health Information Technology Limited
| Estadísticas fundamentales de 241 | |
|---|---|
| Capitalización bursátil | HK$51.46b |
| Beneficios(TTM) | HK$882.00m |
| Ingresos (TTM) | HK$30.46b |
59.6x
Ratio precio-beneficio (PE)1.7x
Ratio precio-ventas (PS)¿Está 241 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 241 | |
|---|---|
| Ingresos | CN¥28.22b |
| Coste de los ingresos | CN¥21.95b |
| Beneficio bruto | CN¥6.27b |
| Otros gastos | CN¥5.45b |
| Beneficios | CN¥817.10m |
Últimos beneficios comunicados
Sep 30, 2023
Próxima fecha de beneficios
May 27, 2024
| Beneficios por acción (BPA) | 0.051 |
| Margen bruto | 22.22% |
| Margen de beneficio neto | 2.90% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado 241 a largo plazo?
Ver rendimiento histórico y comparativa